Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
3.530
-0.170 (-4.59%)
At close: Aug 1, 2025, 4:00 PM
3.670
+0.140 (3.97%)
After-hours: Aug 1, 2025, 6:46 PM EDT
Revance Therapeutics Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $6.6 → $4.5 | Hold | Maintains | $6.6 → $4.5 | +27.48% | Dec 5, 2023 |
| SVB Leerink | SVB Leerink | Buy → Hold Downgrades $30 → $8 | Buy → Hold | Downgrades | $30 → $8 | +126.63% | Aug 29, 2022 |
| Credit Suisse | Credit Suisse | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | May 25, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $42 → $29 | Buy | Maintains | $42 → $29 | +721.53% | Apr 27, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $35 → $42 | Buy | Maintains | $35 → $42 | +1,089.80% | Jan 14, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $36 → $35 | Buy | Maintains | $36 → $35 | +891.50% | Aug 27, 2021 |
| Cowen & Co. | Cowen & Co. | Buy Initiates $50 | Buy | Initiates | $50 | +1,316.43% | Jul 13, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +608.22% | Jun 21, 2021 |